TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/27/23 08:27 | 12/22/23 | ENTX | Entera Bio Ltd. | L3 | Health | BioPrd | Biological Products, (No Diag | Toledano Miranda Jayne | L3 | DO | CEO | P.d | 17 | 0.7100 | 0 | 24 | 28 | 111 | D | ||||||||||||||
4/6/23 16:05 | 4/4/23 | ENTX | Entera Bio Ltd. | L3 | Health | BioPrd | Biological Products, (No Diag | Toledano Miranda Jayne | L3 | DO | CEO | P | 30 | 1.01 | 0 | 30 | 53 | 87 | D | ||||||||||||||
11/14/22 09:13 | 11/11/22 | ENTX | Entera Bio Ltd. | L3 | Health | BioPrd | Biological Products, (No Diag | Toledano Miranda Jayne | L3 | DO | CEO | P | 27 | 0.5317 | 0 | 50 | 735 | 57 | D | ||||||||||||||
1/19/22 16:04 | 1/14/22 | ENTX | Entera Bio Ltd. | L3 | Health | BioPrd | Biological Products, (No Diag | Toledano Miranda Jayne | L3 | D | P | 19 | 2.79 | 0 | 7 | New | 7 | D | |||||||||||||||
1/3/22 16:45 | 12/27/21 | NXGL | Nexgel, Inc. | DE | Health | MdEq | Surgical & Medical Instrument | Toledano Miranda Jayne | PA | D | P.d | 10 | 5.49 | 0 | 2 | New | 2 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |